Coronavirus / S Korea to send 6 lakh COVID-19 testing kits to US after Trump's request: Report

SEOUL - South Korea plans to send kits designed to run up to 600,000 coronavirus tests to the United States on Tuesday after an appeal from U.S. President Donald Trump, a Seoul official said.

Trump made the request in a telephone call with President Moon Jae-in on March 25, as the United States was grappling with fast-growing outbreaks in many states.

South Korean companies have previously shipped test kits to U.S. cities including Los Angeles, but this would mark the first bulk order from the U.S. federal government.

A U.S. Federal Emergency Management Agency cargo plane carrying the equipment is scheduled to leave at 10:30 p.m. (1330 GMT) on Tuesday, the official said on Monday, speaking on condition of anonymity due to the sensitivity of the issue.

South Korea’s foreign minister Kang Kyung-wha confirmed the Reuters report in an interview on French news channel France 24, saying that contracts have been signed and the shipments will be “ready any time soon”.

The first shipments will be handed over to and paid for by the U.S. government, the official told Reuters.

An additional package of kits that can conduct as many as 150,000 tests will be exported in the near future and will be sold through an unspecified local retailer, the official said.

The polymerase chain reaction (PCR) kits will be sourced from three companies that secured preliminary approval late last month from the U.S. Food and Drug Administration (FDA) to export kits to the United States, the official said.

He declined to name the two companies that will provide the shipments on Tuesday.

However, a person with direct knowledge of the matter said, on condition of anonymity, that one of the two firms is Osang Healthcare and the company will provide kits for 300,000 tests.

Calls to Osang Healthcare for a comment were not answered.

Once struggling with the first large outbreak outside China, South Korea has largely managed to bring its coronavirus cases under control without major disruptions thanks to a massive testing campaign and intensive contact tracing.